Clinical trials
Growth clinical trials
Below are recruiting growth clinical trials, each written for real people, not researchers. We’re tracking 296 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07041489Recruiting
Supplement and serum for hair growth in women with thinning hair
This trial tests whether a combination of a dietary supplement and a topical serum can help women with thinning hair grow thicker, fuller hair. It's designed for women who have noticed mild to moderate hair thinning and want a non-invasive approach.
Birmingham, AlabamaAges 28–65 - NCT03919188Recruiting
Compare air versus skin-touch care for very preterm babies
This study looks at two ways of providing control or calming in incubators for very preterm babies (born before 32 weeks) to see how they affect growth and health problems. It may help caregivers learn which method supports safer, healthier development.
Amiens, PicardieAges Up to 1 day - NCT07024407RecruitingPhase 1/Phase 2
Study of andecaliximab for preventing bone growth after spinal cord injury
This trial tests a drug called andecaliximab to see if it can stop abnormal bone growth (heterotopic ossification) that sometimes happens after a spinal cord injury. It is for people who are at high risk for this bone growth and aims to prevent it from forming.
Denver, ColoradoAges 18–89 - NCT07015203Recruiting
First trimester combined screening study
This study offers a combined screening test for pregnant women in their first trimester. It helps check for potential health issues early in pregnancy.
Most, CzechiaAges 18 years+ - NCT07020546Recruiting
Ovarian PRP Injections for Better Embryo Quality
This trial tests whether injecting platelet-rich plasma (PRP) into your ovaries can improve the quality of your embryos. You will go through two IVF cycles, and the treatment aims to help women with low embryo quality get better results.
New York, New YorkAges 18–47 - NCT07010419RecruitingPhase 3
Firmonertinib vs placebo for early-stage lung cancer with rare EGFR mutations
This trial tests if Firmonertinib, a targeted pill, can prevent lung cancer from returning after surgery in people with non-small cell lung cancer that has certain uncommon EGFR gene changes. If you have had complete tumor removal and have one of these specific mutations, this study may help you stay cancer-free longer.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07008703RecruitingPhase 1/Phase 2
Study of sss40 for cancer bone pain
This trial tests a new injection called sss40 to treat moderate-to-severe pain caused by cancer that has spread to the bones. The goal is to see if it is safe and effective for people whose pain is not being controlled by current treatments.
Zhengzhou, HenanAges 18 years+ - NCT07004283Enrolling by invitation
Fetal MRI reference ranges for normal brain development
This study uses fetal MRI scans from a large group of healthy pregnancies to create standard growth charts for brain measurements. This helps doctors better understand normal fetal brain development.
Guangzhou, GuangdongAges 18 years+ - NCT06984822Recruiting
Comparing eye injections for diabetic macular edema
This study compares two different eye injection treatments for diabetic macular edema (DME)—a condition where fluid builds up in the center of the retina, blurring vision. Researchers want to see how certain measures in the blood and in eye scans relate to how well each treatment works.
MölndalAges 18 years+ - NCT06985706RecruitingPhase 3
Comparing two treatments for diabetic eye swelling after initial injections
This trial tests whether switching from anti-VEGF injections to a special laser is better than continuing injections alone for people with diabetic macular edema whose central retinal thickness has dropped below 400 microns after the first year of treatment.
BedfordAges 18 years+ - NCT06970639RecruitingPhase 3
Study comparing new targeted drug plus chemo vs osimertinib for lung cancer with brain tumors
This trial tests a new targeted therapy called furmonertinib combined with chemotherapy against the current standard osimertinib for people with a specific type of non-small cell lung cancer (NSCLC) that has spread to the brain. It aims to find a better treatment option for patients whose cancer cells have a common EGFR mutation.
Guangdong, GuangzhouAges 18 years+ - NCT06956560Recruiting
Heart Scar Imaging Study for Heart Attack and Failure Patients
This study uses a special imaging agent to see a protein called PDGFRß in the heart, which may help detect scarring (fibrosis) after a heart attack or in heart failure. It aims to improve how we understand and treat heart muscle damage.
UppsalaAges 40–70 - NCT06927310RecruitingPhase 3
Growth Hormone Injection for Idiopathic Short Stature in Children
This study tests a new growth hormone injection (Inpegsomatropin) to help children with idiopathic short stature (short stature with no known cause) grow taller. It may be an option if your child is very short compared to peers and has not started puberty.
Hefei, AnhuiAges 3–11 - NCT06909929Enrolling by invitation
High-dose IV lipids for very small or early babies
This study tests whether giving a high dose of a special IV fat solution (called lipids) helps very small or very early-born babies grow better. It's for babies weighing under 1500 grams or born before 32 weeks.
Jakarta, Central JakartaAges Up to 7 months - NCT06895044Recruiting
How myopic children's eyes grow over time
This study follows how the eyes of children with nearsightedness (myopia) grow over time. It aims to learn more about how myopia changes as children get older.
ParisAges 6–17 - NCT05934318Recruiting
Arginine supplements to help prevent pregnancy complications
This study tests whether taking an arginine-based supplement during pregnancy can help lower the risk of bad pregnancy outcomes. You may be eligible if you are pregnant in the early-to-mid period and meet safety and location requirements.
KisumuAges 16–40 - NCT06415487RecruitingPhase 1
Testing a new cell therapy for advanced EGFR-positive solid tumors
This trial tests a new cell therapy called ACE2016 for people with advanced solid tumors that have EGFR on their surface. It may be an option if you have tried at least two other treatments (including a targeted therapy) and your cancer is still growing.
San Diego, CaliforniaAges 18 years+ - NCT06876935Recruiting
Avocado for healthy growth in Hispanic infants
This study tests if feeding avocado to Hispanic infants when they start solids helps their gut health and development. We need families who are ready to offer avocado regularly for about 6 months, starting when their baby is around 6 months old.
Phoenix, ArizonaAges 3 months–6 months - NCT06859424RecruitingPhase 2
Testing a new GVHD prevention method after donor stem cell transplant
This trial tests a new way to prevent graft-versus-host disease (a common side effect of stem cell transplant) using a drug called cyclophosphamide after transplant. It is for adults with certain blood cancers who need a transplant from a partially matched unrelated donor.
Birmingham, AlabamaAges 18–66 - NCT06861309Recruiting
Placental imaging study for pregnant women
This study uses special imaging techniques to look at the placenta during pregnancy. It aims to learn more about normal pregnancies and those where the baby is growing more slowly than expected.
Roanoke, VirginiaAges 18–45 - NCT06266455Recruiting
Nutrition plan to help preterm babies grow and develop
This study tests whether an individualized nutrition plan based on weekly measurements can help preterm infants grow better and improve brain development compared to standard feeding. It is for babies born very early (32 weeks or less) who receive human milk.
Washington D.C., District of ColumbiaAges Up to 4 weeks - NCT06793709Recruiting
Study of Tasfygo for bile duct cancer with FGFR2 gene change
This study is watching people with a certain type of bile duct cancer that has a specific gene change (FGFR2 fusion). It looks at what happens when they take the drug Tasfygo after their cancer did not respond to chemotherapy.
TokyoAges Any age - NCT06779916Recruiting
Placental cell health in pregnancy complications
This study looks at how cells in the placenta handle stress in pregnancies with complications like preeclampsia or poor fetal growth. It aims to understand why some placentas don't work well, which could lead to better treatments.
NîmesAges 18 years+ - NCT06732843Recruiting
Comparing two IVF medications for egg and embryo quality
This study compares two fertility medications (rFSH and hMG) to see how they affect the cells around your eggs and the quality of embryos. It may help you and your doctor choose the best stimulation drug for your IVF cycle.
Abu Dhabi, Abu Dhabi EmirateAges 18–38
Hear when a new Growth trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for growth?
- Yes. Clin2 currently lists 296 recruiting growth studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a growth trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a growth trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.